Daniel Scavilla Net Worth

The estimated Net Worth of Daniel T Scavilla is at least $8.83 Milión dollars as of 2 July 2021. Mr. Scavilla owns over 100,000 units of Globus Medical Inc stock worth over $6,927,000 and over the last 9 years he sold GMED stock worth over $0. In addition, he makes $1,905,540 as Executive Vice President a Chief Commercial Officer at Globus Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Scavilla GMED stock SEC Form 4 insiders trading

Daniel has made over 3 trades of the Globus Medical Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 100,000 units of GMED stock worth $2,590,000 on 2 July 2021.

The largest trade he's ever made was exercising 100,000 units of Globus Medical Inc stock on 2 July 2021 worth over $2,590,000. On average, Daniel trades about 21,429 units every 84 days since 2016. As of 2 July 2021 he still owns at least 100,000 units of Globus Medical Inc stock.

You can see the complete history of Mr. Scavilla stock trades at the bottom of the page.

Daniel Scavilla biography

Daniel T. Scavilla serves as Executive Vice President, Chief Commercial Officer of the Company. He is no longer Chief Financial Officer of the Company, effective August 19, 2019. Mr. Scavilla previously served as our Senior Vice President and Chief Financial Officer from May 2015 to February 2019. Prior to joining Globus, Mr. Scavilla spent 28 years in various positions with Johnson & Johnson, including most recently serving as Chief Financial Officer, Global Vice President Finance & Business Operations of Johnson & Johnson Vision Care from February 2012 to December 2015, and previously as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products, the infection prevention branch of J&J Medical Devices from October 2007 to January 2012. Mr. Scavilla earned a B.S. degree from LaSalle University and an M.B.A. from Temple University.

What is the salary of Daniel Scavilla?

As the Executive Vice President a Chief Commercial Officer of Globus Medical Inc, the total compensation of Daniel Scavilla at Globus Medical Inc is $1,905,540. There are 2 executives at Globus Medical Inc getting paid more, with David Demski having the highest compensation of $3,449,790.

How old is Daniel Scavilla?

Daniel Scavilla is 55, he's been the Executive Vice President a Chief Commercial Officer of Globus Medical Inc since 2019. There are 8 older and 9 younger executives at Globus Medical Inc. The oldest executive at Globus Medical Inc is James Tobin, 75, who is the Independent Director.

What's Daniel Scavilla's mailing address?

Daniel's mailing address filed with the SEC is VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403.

Insiders trading at Globus Medical Inc

Over the last 12 years, insiders at Globus Medical Inc have traded over $375,265,297 worth of Globus Medical Inc stock and bought 2,005 units worth $99,824 . The most active insiders traders include David C Paul, Kurt Wheeler a David M Demski. On average, Globus Medical Inc executives and independent directors trade stock every 42 days with the average trade being worth of $11,005,133. The most recent stock trade was executed by Leslie V Norwalk on 11 July 2024, trading 1,000 units of GMED stock currently worth $70,000.

What does Globus Medical Inc do?

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

Complete history of Mr. Scavilla stock trades at Globus Medical Inc

Globus Medical Inc executives and stock owners

Globus Medical Inc executives and other stock owners filed with the SEC include:

• David Demski,
  President, Chief Executive Officer, Director
• David Paul,
  Executive Chairman of the Board
• Daniel Scavilla,
  Executive Vice President, Chief Commercial Officer
• David M. Demski,
  CEO, Pres & Director
• Kelly Huller,
  Senior Vice President, General Counsel, Corporate Secretary
• David C. Paul,
  Co-Founder & Exec. Chairman
• Daniel T. Scavilla,
  Exec. VP, Chief Commercial Officer & Pres of Trauma
• Keith Pfeil,
  Chief Financial Officer, Senior Vice President
• Keith W. Pfeil,
  Sr. VP & CFO
• Kelly G. Huller Esq.,
  Sr. VP & Gen. Counsel
• Ann Rhoads,
  Independent Director
• Robert Douglas,
  Independent Director
• James Tobin,
  Independent Director
• Daniel Lemaitre,
  Independent Director
• Steve Zarrilli,
  Independent Director
• David Davidar,
  Independent Director
• Richard Holifield,
  Exec. Officer
• Mike Reeder,
  Exec. Officer
• Steven M. Payne,
  VP & Controller
• A. Brett Murphy,
  Exec. VP of International Sales
• Brian J. Kearns,
  Sr. VP of Bus. Devel. & Investor Relations
• John A De Ford,
  
• Kurt Wheeler,
  Director
• Robert Liptak,
  Director
• Steven Payne,
  Chief Accounting Officer
• Anthony L Williams,
  President
• Stephen T Zarrilli,
  
• Leslie V Norwalk,
  
• Dan Wolterman,
  
• Dan Lemaitre,
  
• A Brett Murphy,
  Executive VP, US Sales
• Eric Schwartz,
  Senior VP and General Counsel
• Sachs & Cogoldman Sachs Gro...,
  
• Lifesciences I, L.P.Clarus ...,
  
• Sachs Pep 2004 Offshore Hol...,
  
• Richard A Baron,
  Senior VP and CFO
• Sachs Group Incgoldman Sach...,
  
• Sachs Private Equity Partne...,